Related Experiment Video
Updated: Apr 5, 2026
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Important complications of chronic kidney disease
I Van der Walt1, C R Swanepoel, B Mahala
1Netcare Jakaranda Hospital, Pretoria, South Africa. walt@sagateway.com.
Insights
Managing chronic kidney disease (CKD) complications like acidosis and anemia is crucial. Early treatment of metabolic acidosis with sodium bicarbonate and maintaining target hemoglobin levels can help manage CKD progression and associated risks.
Area of Science:
- Nephrology
- Internal Medicine
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) presents multiple complications including dyslipidemia, hyperkalemia, metabolic acidosis, anemia, and mineral and bone disorders.
- Dyslipidemia management in CKD varies by stage, with statins indicated for earlier stages but ineffective in advanced CKD (stages 4 and 5).
- Metabolic acidosis is a newly identified risk factor for CKD progression, necessitating mandatory treatment.
Purpose of the Study:
- To review the complications of chronic kidney disease (CKD).
- To discuss the management of dyslipidemia, metabolic acidosis, anemia, and mineral and bone disorders in CKD.
- To highlight the importance of treating metabolic acidosis and anemia to prevent CKD progression and cardiovascular disease.
Main Methods:
- Literature review of CKD complications and their management.
- Analysis of treatment strategies for dyslipidemia, metabolic acidosis, anemia, and mineral and bone disorders.
- Discussion of the impact of CKD complications on cardiovascular health.
Main Results:
- Statins are effective for dyslipidemia in early CKD but not in stages 4 and 5.
- Sodium bicarbonate is an inexpensive and safe treatment for metabolic acidosis in CKD, without raising blood pressure.
- Target hemoglobin levels are 10-12 g/dL; elevated phosphate and parathyroid hormone levels in advanced CKD are significant cardiovascular risk factors.
Conclusions:
- Effective management of CKD complications, including metabolic acidosis and anemia, is essential for slowing disease progression.
- Treatment of metabolic acidosis with sodium bicarbonate is a safe and effective strategy.
- Addressing mineral and bone disorders and maintaining target hemoglobin levels are critical for reducing cardiovascular risk in CKD patients.
Abstract:
The complications of chronic kidney disease (CKD) are dyslipidaemia, hyperkalaemia, metabolic acidosis, anaemia, and bone and mineraldisorders. Dyslipidaemia may be treated with low-density lipoprotein-lowering agents. Statins are ineffective in stages 4 and 5 CKD, but areindicated for preventing the progression of disease in the earlier stages. Chronic acidosis has recently been shown to be a risk factor in theprogression of CKD renal dysfunction. Therefore, treatment is mandatory. Practically, this should consist of 1 - 2 heaped teaspoons of sodiumbicarbonate 2 - 3 times per day, which is an inexpensive and safe therapy that does not raise the blood pressure in spite of the increased sodiumlevel. Target levels of haemoglobin, according to international guidelines, are between 10 g/dL and 12 g/dL. The serum phosphate level is raisedin stage 4 CKD, and especially in stage 5 CKD, which is associated with coronary carotid and other vascular calcifications and may result inischaemic heart disease, myocardial infarction and stroke. A raised parathyroid hormone level (secondary hyperparathyroidism) is also a majorrisk factor for cardiovascular disease and is associated with increased hypertension and resistance to the treatment of CKD-associated anaemia.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
01:24Chronic Kidney Disease II: Clinical Manifestations
01:28Chronic Kidney Disease III: Interprofessional Care
01:18Chronic Kidney Disease IV: Nursing Management
01:10Nephrons
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications